Send feedback

EP300 p.Asp1485=

c.4455T>C · VCV3678394

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
very rare (popmax 0.00212%, nfe)
Conditions
1
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI<0.2all four deltas below 0.2 · T>G here scores Δ0.27 · evaluated, not missing
Constraint at this position
ConservationphyloP 1.2GERP 0.39, phastCons 1
Overall
CADD12.6PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00212% European (non-Finnish) · 25/1,178,492 alleles
Filtering AF 0.00146% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00123%
Overall 0.00161% 26/1,612,306 alleles · very rare
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.00212% 47,140
Remaining individualsnot grpmax-eligible 0.0016% 62,434

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
EP300
Protein
p.Asp1485=
Coding
c.4455T>C
MANE Select
NM_001429
Type
single nucleotide variant
Location
chr22:41172501 (GRCh38)
Gene constraint
LOEUF 0.164 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 54.88 · 60 PDB
Residue 1485
a β-strand; the cbp/p300-type hat domain
Full EP300 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ep300-p-asp1485 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown